Heads the group
JM CAPITAL
11 companies
Group, risk and exposure
Holdings and subsidiaries
7 holdings · 7 subsidiaries, including indirect onesHoldings 7
Source for every holding own accounts 2025
- APOTHEEK HEYLENsubsidiaryEquity €735,700 Profit of €225,585 in 2025 (profit of €197,773 in 2024) Checked score 96100%
- APOTHEEK TANGHEsubsidiaryEquity €163,978 Loss of €173,389 in 2025 (loss of €182,886 in 2024) Checked score 48100%
- Apotheek Van HoeckesubsidiaryEquity €358,920 Profit of €77,634 in 2025 (profit of €62,614 in 2024) Checked score 96100%
- DERMATHEEKsubsidiaryEquity €804,196 Profit of €243,862 in 2024 (profit of €307,131 in 2023) Checked score 50100%
- P.J.A. BEHEERsubsidiaryEquity €7.5m Profit of €29,661 in 2025 (profit of €23,327 in 2024) Checked score 96100%
- PJA RetailsubsidiaryEquity -€225,546 Loss of €53,079 in 2025 (loss of €49,269 in 2024) Checked score 46100%
- Equity €1.7m Profit of €87,523 in 2025 (profit of €345,021 in 2024)50%
Former holdings (1)
This company merged into JM CAPITAL on 07-09-2026.
- Equity €556,748 Profit of €164,322 in 2025 (profit of €124,407 in 2024)100%
All subsidiaries, including indirect ones 7
JM CAPITAL or one of its subsidiaries holds more than half of the shares of these companies. A company it consolidates per the LEI register is listed too.
- APOTHEEK HEYLEN 100%
- APOTHEEK TANGHE 100%
- Apotheek Van Hoecke 100%
- DERMATHEEK 100%
P.J.A. BEHEER 100%1 subsidiary
- PJA CONSTRUCT 96%
- PJA Retail 100%
Board mandates elsewhere
3 board mandatesBoard mandates of JM CAPITALJM CAPITAL sits on their board3
Acquisitions and mergers
1 transactionTook over:BEAUPHAR
Companies at the same address
4 other companiesConnections & network
2 current directorsThe board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.